I would like to extend our thanks to Duncan and the team at Broadfield. Their professionalism, advice and guidance are greatly appreciated. Early diagnosis is a critical determinant of health outcomes. By enabling swift and non-invasive detection of disease, breath analysis has the potential to save lives and dramatically reduce healthcare costs in a wide range of applications. This investment is a testament to how Owlstone is uniquely positioned to transform breath-based disease diagnosis through our Breath Biopsy platform.